Schroder Investment Management Group’s Zenas BioPharma ZBIO Stock Holding History

Schroder Investment Management Group’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$614K	Sell	33,697 -16,939	-33%	-$380K	﹤0.01%	1073
2025 Q4	$1.85M	Sell	50,636 -61,976	-55%	-$2.04M	﹤0.01%	901
2025 Q3	$2.32M	Sell	112,612 -42,304	-27%	-$689K	﹤0.01%	904
2025 Q2	$1.48M	Sell	154,916 -9,119	-6%	-$88.8K	﹤0.01%	950
2025 Q1	$1.34M	Sell	164,035 -7,905	-5%	-$61.9K	﹤0.01%	954
2024 Q4	$1.55M	Buy	+171,940	New	+$2.68M	﹤0.01%	955

Other funds holding ZBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Schroder Investment Management Group's ZBIO Position: Q1 2026 in Review

Schroder Investment Management Group reduced its Zenas BioPharma (ZBIO) stake by 33% in Q1 2026, selling an estimated $380K and leaving 33,697 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Schroder Investment Management Group first reported a position in ZBIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.32M in Q3 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

Schroder Investment Management Group held 33,697 shares of Zenas BioPharma worth $614K as of Q1 2026.
Schroder Investment Management Group sold 16,939 Zenas BioPharma shares in Q1 2026, an estimated $380K.
Zenas BioPharma made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #1073 holding.
Schroder Investment Management Group first reported a position in Zenas BioPharma in Q4 2024 and has held it in 6 quarters since.
Schroder Investment Management Group's Zenas BioPharma position peaked at $2.32M in Q3 2025.
139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.